Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

What is oral immunotherapy? Learn how this new therapy could help children treat their peanut allergies, but how there is ...

British shoppers have been warned that an urgent food recall is being extended, affecting anyone with a peanut allergy.

Australia is grappling with a surge in venomous red fire ant populations after heavy rains forced them above ground. These ...

FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...

Studies show that eating two and a half servings of strawberries per day may reduce low-density lipoprotein concentrations ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced ...

The potato plant looks pretty attractive, but the leaves and stems are not edible. They contain solanine, arsenic, and ...

ARS Pharmaceuticals, Inc.'s stock soared 25% on strong earnings. Learn about neffy's market potential, risks, and future ...

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...

Symptoms that warrant immediate emergency care, from chest pain to severe allergic reactions, and when urgent care or ...

The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...